ICR-CTSU Gynaecological Cancers Trials and Imaging Studies

Dr Nuria Porta’s group within the ICR’s Clinical Trials and Statistics Unit carries out clinical trials research in gynaecological and urology cancers, and imaging studies.

Go to a group in this division

Research, projects and publications in this group

We are a multidisciplinary group of statisticians, methodologists, clinical trial programme managers, trial managers and data scientists within the ICR’s Clinical Trials and Statistics Unit (ICR-CTSU).

We develop and deliver efficient, high-quality and innovative trials in gynaecological and urology cancers, and studies of prospective evaluation of imaging interventions, with a focus on biomarker-driven designs and risk-adaptive strategies and qualification of novel response biomarkers.

We maximise the use of data collected within a clinical trial through advanced statistical modelling of clustered and correlated data over time (dynamic prediction modelling) to better understand biological and clinical events related to the disease and/or treatment.

Dr Nuria Porta

Group Leader:

ICR-CTSU Gynaecological Cancers Trials and Imaging Studies

Nuria Porta is Reader in Medical Statistics and Group Leader at the Cancer Research UK-funded Clinical Trials and Statistics Unit at The Institute of Cancer Research (ICR-CTSU).

See profile